The tantalizing triplet of pulmonary hypertension - BMP receptors, serotonin receptors, and angiopoietins

Cardiovascular Research

Volumn 60, Issue 3, 2003, Pages 465-467

  Eickelberg, Oliver ^a   Yeager, Michael E ^a   Grimminger, Friedrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; DEXFENFLURAMINE; FENFLURAMINE; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANAMNESIS; AUTOSOMAL DOMINANT DISORDER; CLINICAL RESEARCH; DISEASE COURSE; EDITORIAL; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC LINKAGE; HETEROZYGOSITY; HUMAN; LUNG ARTERY PRESSURE; MEDICAL RESEARCH; MOLECULAR CLONING; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RISK FACTOR; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANGIOPOIETINS; BONE MORPHOGENETIC PROTEIN RECEPTORS; HUMANS; HYPERTENSION, PULMONARY; MUTATION; RECEPTORS, GROWTH FACTOR; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION;

EID: 0345490694     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.10.017     Document Type: Editorial

References (19)

1. Gaine S.P., Rubin L.J. Primary pulmonary hypertension. Lancet. 352(9129):1998;719-725.
2. Runo J.R., Loyd J.E. Primary pulmonary hypertension. Lancet. 361(9368):2003;1533-1544.
3. Dresdale D.T., Michtom R.J., Schultz M. Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. Bull. N. Y. Acad. Med. 30(3):1954;195-207.
4. Loyd J.E., Primm R.K., Newman J.H. Familial primary pulmonary hypertension: clinical patterns. Am. Rev. Respir. Dis. 129(1):1984;194-197.
5. Nichols W.C., Koller D.L., Slovis B., Foroud T., Terry V.H., Arnold N.D.et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat. Genet. 15(3):1997;277-280.
6. Morse J.H., Jones A.C., Barst R.J., Hodge S.E., Wilhelmsen K.C., Nygaard T.G. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation. 95(12):1997;2603-2606.
7. Deng Z., Morse J.H., Slager S.L., Cuervo N., Moore K.J., Venetos G.et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet. 67(3):2000;737-744.
8. Lane K.B., Machado R.D., Pauciulo M.W., Thomson J.R., Phillips J.A. III, Loyd J.E.et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet. 26(1):2000;81-84.
9. Rudarakanchana N., Flanagan J.A., Chen H., Upton P.D., Machado R., Patel D.et al. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum. Mol. Genet. 11(13):2002;1517-1525.
10. Nishihara A., Watabe T., Imamura T., Miyazono K. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol. Biol. Cell. 13(9):2002;3055-3063.
11. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X.et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group. N. Engl. J. Med. 335(9):1996;609-616.
12. Humbert M., Deng Z., Simonneau G., Barst R.J., Sitbon O., Wolf M.et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur. Respir. J. 20(3):2002;518-523.
13. Abramowicz M.J., Van Haecke P., Demedts M., Delcroix M. Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation. Eur. Respir. J. 22(3):2003;560-562.
14. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
15. Herve P., Drouet L., Dosquet C., Launay J.M., Rain B., Simonneau G.et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med. 89(1):1990;117-120.
16. Eddahibi S., Humbert M., Fadel E., Raffestin B., Darmon M., Capron F.et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108(8):2001;1141-1150.
17. Launay J.M., Herve P., Peoc'h K., Tournois C., Callebert J., Nebigil C.G.et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat. Med. 8(10):2002;1129-1135.
18. Du L., Sullivan C.C., Chu D., Cho A.J., Kido M., Wolf P.L.et al. Signaling molecules in nonfamilial pulmonary hypertension. N. Engl. J. Med. 348(6):2003;500-509.
19. Sullivan C.C., Du L., Chu D., Cho A.J., Kido M., Wolf P.L.et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc. Natl. Acad. Sci. U. S. A. 100(21):2003;12331-12336.